欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0841/001
药品名称
Quatriga
活性成分
histidine 1.5 g
methionine 2.2 g
sodium acetate 1.7 g
sodium glycerophosphate 2.1 g
serine 3.3 g
proline 5.7 g
potassium chloride 2.3 g
magnesium sulfate 0.61 g
lysine 3.4 g
isoleucine 2.5 g
glycine 5.6 g
glucose monohydrate 127.0 g
fish oil, rich in omega 3-acids 5.7 g
calcium chloride 0.28 g
arginine 6.1 g
alanine 7.1 g
phenylalanine 2.6 g
olive oil monohydrate 9.5 g
medium-chain triglycerides 11.4 g
zinc sulfate 0.0 g
valine 3.1 g
tyrosine 0.12 g
tryptophan 0.63 g
threonine 2.2 g
taurine 0.5 g
soybean oil monohydrate 11.4 g
leucine 3.8 g
剂型
Emulsion for infusion
上市许可持有人
Fresenius Kabi AB 751 74 Uppsala Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Italy (IT)
许可日期
2009/09/01
最近更新日期
2024/04/16
药物ATC编码
B05BA10 combinations
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Bibliographic Art 10 a Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE/H/0841/001_Final PL
Date of last change:2014/01/15
Final SPC
|
SE/H/0841/001_Final SPC
Date of last change:2014/01/15
PAR
|
SE/H/0841/001_PAR
Date of last change:2014/01/15
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase